Patient Search
 |
 |
|
KaCrole Higgins was diagnosed with breast cancer in 2020. “In May 2020, I found a lump in my breast. I cried. By June, it was diagnosed as breast cancer, triple positive, stage 1A. While getting this cancer diagnosis was devastating, it also became an opportunity. Suddenly, the cancer gave me clarity. It gave me clarity about what was important, what was good in my life, what was toxic in my life, and what I needed to do.” Click below to read more of KaCrole’s story |
If Landon Ryan had been diagnosed with bilateral retinoblastoma 10, 20 or 30 years ago, she might not be here today with nearly perfect vision.Thanks to recent improvements in the treatment for this rare form of cancer that almost exclusively affects children under the age of 5, the diagnosis had the power to change Landon’s life when she was 11 months old, but not to take it — or her eyesight. Click below to learn more about Landon and her story. https://momentum.vicc.org/2022/04/brighter-outlook/ |
A non-randomized prospective clinical trial comparing the non-inferiority of Salpingectomy to Salpingo-oophorectomy to reduce the risk of ovarian cancer among BRCA1 carriers [sorock]
Ovarian
Ovarian
Ovarian
N/A
Brown, Alaina
NCT04251052
NRGGYNCC008
A Randomized Phase III Study of Systemic Therapy with or without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial
Not Available
III
Padmanabhan, Sekhar
NCT05863195
VICC-NTGIT23530
M23-384: A Phase 3 Randomized, Open Label, Multicenter Study to Evaluate the Safety and Efficacy of ABBV-706 versus Standard of Care in Subjects with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
Lung
Lung
Lung
III
Wang, Shuai
NCT07365241
VICCTHO26004
Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS >/= 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)
Not Available
II/III
Agarwal, Rajiv
NCT06203600
SWOGGIS2303
A Phase 1a/1b Open-Label, Multicenter, Dose Escalation, and Dose Expansion Trial to Evaluate the Safety and Activity of TEV-56278, as a Monotherapy and in Combination with Pembrolizumab in Participants with Selected Locally Advanced or Metastatic Solid Tumors
Miscellaneous
Miscellaneous
Miscellaneous
I
Johnson, Douglas
NCT06480552
VICC-DTPHI24182
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
II
Sengsayadeth, Salyka
NCT05972135
VICCPCL24566
A Phase 2b/3, Randomized, Double-Blind Study to Investigate the Efficacy, Safety, and Tolerability of Ponsegromab (PF-06946860) Compared with Placebo Both with Background First-Line Chemotherapy in Adult Participants with Cachexia and Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic
Pancreatic
Pancreatic
II/III
Agarwal, Rajiv
NCT06989437
VICCSUPP25038
A Randomized Double-Blind Placebo-Controlled Phase II Multi-Center Study of Inflammation Modification of Canakinumab to Prevent Leukemic Progression of Clonal Cytopenias of Unknown Significance (CCUS): IMPACT Study
Leukemia
Leukemia
Leukemia
II
Kishtagari, Ashwin
NCT05641831
VICC-ITHEM23019
A Randomized Phase III Trial Comparing Radiation Therapy (RT) Plus Carboplatin/Paclitaxel vs. RT Plus Cetuximab for Patients with Locoregionally Advanced Head and Neck Cancer Who Have a Contraindication to Cisplatin (CONCISE)
Head/Neck
Head/Neck
Head/Neck
III
Choe, Jennifer
NCT07441681
NRGHNHN016
A Phase III Trial of One vs. Two Years of Maintenance Olaparib, With or Without Bevacizumab, in Patients With BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum Based Chemotherapy
Multiple Cancer Types
Gynecologic,
Ovarian
III
Brown, Alaina
NCT06580314
NRGGYNGY036
